True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature

Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy

(2021) Shengnan Jin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA

(2021) Huiyan Luo et al.   TRENDS IN MOLECULAR MEDICINE

Use of Circulating Cell-Free DNA to Guide Precision Medicine in Patients with Colorectal Cancer

(2021) Van K. Morris et al.   Annual Review of Medicine

Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis

(2021) Robert P. Jones et al.   EUROPEAN JOURNAL OF CANCER

Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives

(2020) E. Martinelli et al.   ANNALS OF ONCOLOGY

Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis

(2020) Daniele Rossini et al.   Clinical Colorectal Cancer

Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy

(2020) Takeshi Yamada et al.   International Journal of Clinical Oncology

Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy

(2020) Hiu Ting Chan et al.   Molecular Oncology

Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer

(2020) Francesca Belardinilli et al.   Frontiers in Oncology

Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer

(2020) Susanne Klein-Scory et al.   Frontiers in Oncology

478P RAS mutation clearance in patients with metastatic colorectal cancer

(2020) L. Huiyan et al.   ANNALS OF ONCOLOGY

Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer

(2020) Valeria Internò et al.   Frontiers in Oncology

Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing

(2020) Matilda Holm et al.   PLoS One

Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients

(2020) Chiara Nicolazzo et al.   Cancers

Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer

(2019) Cristina Raimondi et al.   Cancers

A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer

(2019) Carlo Capalbo et al.   Cancers

Mechanisms of Innate and Acquired Resistance to Anti-EGFR therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies

(2019) Christine M. Parseghian et al.   CLINICAL CANCER RESEARCH

Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples

(2019) Ana Vivancos et al.   Scientific Reports

Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer

(2019) Emilie Moati et al.   INTERNATIONAL JOURNAL OF CANCER

Clinical Application of Next-Generation Sequencing as A Liquid Biopsy Technique in Advanced Colorectal Cancer: A Trick or A Treat?

(2019) Myrto Kastrisiou et al.   Cancers

Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer

(2019) Chiara Nicolazzo et al.   Frontiers in Oncology

Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors

(2018) Yu Sunakawa et al.   World Journal of Gastrointestinal Oncology

Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies

(2018) Gianluca Mauri et al.   CANCER TREATMENT REVIEWS

Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer

(2017) Ludovic Barault et al.   GUT

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

(2012) Sandra Misale et al.   NATURE